efficacy

REVIEW – Statins Boost Abiraterone (Zytiga) Activity in Prostate Cancer

Another piece of information from the recent ASCO GU conference in San Francisco Researchers have found that adding statin drugs may prolong the sensitivity of abiraterone acetate (Zytiga) in men with castration-resistant prostate cancer (CRPC) To assess the effect of statins on abiraterone therapy, Dr Harshman, of the Lank Center for Genitourinary Oncology at Dana-Farber [...]

By Malecare|2017-10-19T10:46:40-04:00January 14th, 2016|abiraterone acetate, Advanced Prostate Cancer, ASCO, Drugs & Treatments, Research, statins, Survival, Uncategorized|0 Comments

German Registry Data Analysis of Degarelix (Firmagon®) for Prostate Cance

The newest gonadotropin-releasing hormone (GnRH) antagonist therapy drug, degarelix (aka Firmagon) has become more commonly used in everyday clinical practice as an alternative hormone therapy treatment drug (ADT). Given that its use has become common it is important to understand both its safety and efficacy as compared to our older standard drugs. The best way [...]

By Malecare|2017-10-19T10:46:41-04:00December 23rd, 2015|ADT, Advanced Prostate Cancer, Clinical Trials & Research, Drugs & Treatments, Firmagon (degarelix), Germany, Hormone Therapy, Research, Survival, Uncategorized|1 Comment